Usha Krishnan, Jeffrey A. Feinstein, Ian Adatia, Eric D. Austin, Mary P. Mullen, Rachel K. Hopper, Brian Hanna, Lew Romer, Roberta L. Keller, Jeffrey Fineman, Robin Steinhorn, John P. Kinsella, D. Dunbar Ivy, Erika Berman Rosenzweig, Usha Raj, Tilman Humpl, Steven H. Abman, for the Pediatric Pulmonary Hypertension Network (PPHNet)Columbia University Medical Center and Morgan […]
Brandon R. Jakubowski, Megan Griffiths, Kara N. GossUniversity of Texas Southwestern Medical Center.United States Radiology Clinics of North AmericaRadiol Clin North Am 2025; 63: 305-313DOI: 10.1016/j.rcl.2024.07.008 AbstractPulmonary vascular diseases, particularly when accompanied by pulmonary hypertension, are complex disorders often requiring multimodal imaging for diagnosis and monitoring. Echocardiography is the primary screening tool for pulmonary hypertension, while
The Role of Imaging in Pulmonary Vascular Disease: The Clinician’s Perspective Read More »
Bibhuti B. DasUniversity of Mississippi Medical Center.United States Current Cardiology ReportsCurr Cardiol Rep 2025; 27:DOI: 10.1007/s11886-024-02157-9 AbstractPurpose of review: Traditionally viewed as a passive player in circulation, the right ventricle (RV) has become a pivotal force in hemodynamics. RV failure (RVF) is a recognized complication of primary cardiac and pulmonary vascular disorders and is associated with a
Novel Therapies for Right Ventricular Failure Read More »
Ying-Zhen Zhou, Ting Wang, Xing-Meng Fu, Bing-Ming Peng, Zhou FuChildren’s Hospital of Chongqing Medical University and National Clinical Research Center for Child Health and Disorders.China Chinese Journal of Contemporary PediatricsZhongguo Dang Dai Er Ke Za Zhi 2025; 27: 115-120DOI: 10.7499/j.issn.1008-8830.2406004 AbstractChildren with bronchopulmonary dysplasia (BPD) often exhibit severe respiratory problems and significant pulmonary dysfunction during school
[Prognosis of bronchopulmonary dysplasia] Read More »
Fabian Doktor, Lina Antounians, Rebeca Lopes Figueira, Kasra Khalaj, Miriam Duci, Augusto ZaniHospital for Sick Children and University of Toronto. Leipzig University.Canada and Germany Stem Cells Translational MedicineStem Cells Transl Med 2025; 14: DOI: 10.1093/stcltm/szae095 AbstractDisruption of developmental processes affecting the fetal lung leads to pulmonary hypoplasia. Pulmonary hypoplasia results from several conditions including congenital diaphragmatic
Suneesh C. Anand, Muhammad Furqan, Adriano R. Tonelli, Daniela Brady, Avi Levine, Erika B. Rosenzweig, William H. Frishman, Wilbert S. Aronow, Gregg M. LanierHillcrest Hospital and Cleveland Clinic. New York Medical College, Maria Fareri Children’s Hospital of Westchester and Westchester Medical Center.United States Cardiology in ReviewCardiol Rev 2025; DOI: 10.1097/CRD.0000000000000837 AbstractPulmonary arterial hypertension (PAH) is a
Sotatercept: A New Era in Pulmonary Arterial Hypertension Read More »
Lindsay M. Forbes, Natalie Bauer, AritraBhadra, Stefan Gräf, GustavoA.Heresi, Rachel K. Hopper, Harm J. Bogaard, Gaurav Choudhary, Kara N. Goss, Arun Jose, Yunhye Kim, Timothy Klouda, Tim Lahm, Allan Lawrie, Peter J. Leary, Jane A. Leopold, Suellen D. Oliveira, Christopher J. Rhodes, Duncan J. Stewart, Rebecca R. Vanderpool, Sasha Z. Prisco, Ruslan Rafikov, Ke Yuan,
Roberto Chiletti, Sophie H. Fincher, Stephen B. Horton, Giles J. Peek, Paul Checchia, Warwick ButtRoyal Children’s Hospital and University of Melbourne. University of Florida. Texas Children’s Hospital and the Baylor College of Medicine. Australia and United States Canadian Journal of CardiologyCan J Cardiol 2024; DOI: 10.1016/j.cjca.2024.12.027 AbstractNitric oxide (NO) was proclaimed the 1992 “molecule of the
Ranjan Banerjee, Alexander R. OpotowskyCincinnati Children’s Hospital and University of Cincinnati College of MedicineUnited States International Journal of Cardiology Congenital Heart DiseaseInt J Cardiol Congenit Heart Dis 2024; DOI: 10.1016/j.ijcchd.2024.100520 AbstractLongstanding left-to-right shunting associated with congenital heart disease (CHD) can ultimately lead to pulmonary vascular remodeling, pulmonary arterial hypertension, and shunt reversal, the hallmark feature of
Warren A. Williamson, Bruce S. Tronic, Nathan Levitan, David G. Webb-Johnson, David M. Shahian, F. Henry Ellis, Jr.Lahey Clinic Medical Center.United States ChestChest 1992; 102: 937-940DOI: 10.1378/chest.102.3.937 AbstractPulmonary venous infarction, although rare, can develop in patients with the various pathologic conditions outlined. The triad of cough, dyspnea, and hemoptysis should raise clinical suspicion. The venous phase
Pulmonary venous infarction Read More »
